SCHEMBL16984476

SCHEMBL16984476

CC(CCNC(=O)OC(C)(C)C)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 3/20 0.42
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
HTT P42858 1/20 0.39
GPR88 Q9GZN0 1/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
EPHX1 P07099 1/20 0.36
KCNA5 P22460 1/20 0.36
ATM Q13315 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GFER P55789 1/20 0.35
PCSK9 Q8NBP7 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL755781 0.86 MEN1 (0.47) MEN1GAAKMT2ATDP1MAOA
SCHEMBL31236578 0.84 MEN1 (0.46) MEN1GAAKMT2ATDP1MAOA
SCHEMBL14481608 0.84 CYP2D6 (0.32) MEN1GAAKMT2A
SCHEMBL755887 0.81 MEN1 (0.55) MEN1GAAKMT2ATDP1MAOA
SCHEMBL23637197 0.80 MEN1 (0.53) MEN1GAAKMT2ATDP1MAOA
SCHEMBL18897496 0.80 MEN1 (0.53) MEN1GAAKMT2ATDP1MAOA
SCHEMBL1143295 0.79 TDP1 (0.49) MEN1GAAKMT2ATDP1MAOA
SCHEMBL12143236 0.78 TDP1 (0.50) MEN1GAAKMT2ATDP1MAOA
SCHEMBL13405157 0.78 MEN1 (0.48) MEN1GAAKMT2ATDP1MAOA
SCHEMBL30644074 0.77 APLNR (0.36) MEN1GAAKMT2ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9662310-B2 Cyclopropanecarboxylic acid derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2017-05-30 US disclosed
US-20150216847-A1 CYCLOPROPANECARBOXYLIC ACID DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150216847-A1 CYCLOPROPANECARBOXYLIC ACID DERIVATIVE TFPI, TFPI2, TAF11 MEN1 4355/4885GAA 3093/4885KMT2A 4515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.